-
1
-
-
0034102104
-
Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease
-
Meltzer EO. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease". Ann Allergy Asthma Immunol 2000;84:176-87.
-
(2000)
Ann Allergy Asthma Immunol
, vol.84
, pp. 176-187
-
-
Meltzer, E.O.1
-
2
-
-
0026427907
-
Allergic rhinitis
-
Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325: 860-9.
-
(1991)
N Engl J Med
, vol.325
, pp. 860-869
-
-
Naclerio, R.M.1
-
4
-
-
0034933318
-
Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: Contribution of dekated mucosal blood vessels
-
Mizutani N, Nabe T, Imai A, Sakurai H, Takenaga. H, Kohno S. Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dekated mucosal blood vessels. Jpn J Pharmacol 2001;86:170-82.
-
(2001)
Jpn J Pharmacol
, vol.86
, pp. 170-182
-
-
Mizutani, N.1
Nabe, T.2
Imai, A.3
Sakurai, H.4
Takenaga, H.5
Kohno, S.6
-
5
-
-
12144286468
-
Montelukast for treating fall allergic rhinitis: Effect of pollen exposure in 3 studies
-
Chervinsky P, Philip G, Malice MP et al. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol 2004;92:367-73.
-
(2004)
Ann Allergy Asthma Immunol
, vol.92
, pp. 367-373
-
-
Chervinsky, P.1
Philip, G.2
Malice, M.P.3
-
8
-
-
0033460212
-
Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL,5-expressing cells in Brown Norway rats
-
Ihaku D, Cameron L, Suzuki M, Molet S, Martin J, Hamid Q. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL,5-expressing cells in Brown Norway rats. J Allergy Clin Immunol 1999;104:1147-54.
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 1147-1154
-
-
Ihaku, D.1
Cameron, L.2
Suzuki, M.3
Molet, S.4
Martin, J.5
Hamid, Q.6
-
9
-
-
0036204826
-
Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast
-
Minoguchi K, Kohno Y, Minoguchi, H et al. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest 2002;121:732-8.
-
(2002)
Chest
, vol.121
, pp. 732-738
-
-
Minoguchi, K.1
Kohno, Y.2
Minoguchi, H.3
-
10
-
-
0035987308
-
Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, Placebo-controlled trial performed in the spring
-
Philip G, Malmstrom K, Hampel FC et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, Placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32:1020-8.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 1020-1028
-
-
Philip, G.1
Malmstrom, K.2
Hampel, F.C.3
-
11
-
-
0036627769
-
Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial performed in the fall
-
Nayak AS, Philip G, Lu S, Malice MP, Reiss TF. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88: 592-600.
-
(2002)
Ann Allergy Asthma Immunol
, vol.88
, pp. 592-600
-
-
Nayak, A.S.1
Philip, G.2
Lu, S.3
Malice, M.P.4
Reiss, T.F.5
-
12
-
-
0037326761
-
-
Van Adelsberg J, Philip G, La Force CF et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003;90:214-22.
-
Van Adelsberg J, Philip G, La Force CF et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003;90:214-22.
-
-
-
-
13
-
-
0345256573
-
-
Van Adelsberg J, Philip G, Pedinoff AJ et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003;58:1268-76. Erratum in: Allergy 2004; 59:357.
-
Van Adelsberg J, Philip G, Pedinoff AJ et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003;58:1268-76. Erratum in: Allergy 2004; 59:357.
-
-
-
-
14
-
-
7644224295
-
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis
-
Philip G, Nayak AS, Berger WE et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20: 1549-58.
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 1549-1558
-
-
Philip, G.1
Nayak, A.S.2
Berger, W.E.3
-
15
-
-
17144430933
-
Onset of efficacy of montelukast in seasonal allergic rhinitis
-
Weinstein SF, Philip G, Hampel FC Jr et al. Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy Asthma Proc 2005;26:41-6.
-
(2005)
Allergy Asthma Proc
, vol.26
, pp. 41-46
-
-
Weinstein, S.F.1
Philip, G.2
Hampel Jr, F.C.3
|